A. Gimenez-Manzorro

发表

Effectiveness of an electronic tool for medication reconciliation in a general surgery department

R. Plá-Mestre, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2015, International Journal of Clinical Pharmacy.

Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2018, Journal of clinical pharmacy and therapeutics.

Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain

C. Rodriguez-Gonzalez, C. Sarobe-González, E. Bouza, 2021, Expert review of clinical pharmacology.

Antiangiogenic Drugs and Cardiogenic Shock: A Case Report

M. Sanjurjo-Sáez, A. Gimenez-Manzorro, L. Cortejoso, 2014, American journal of therapeutics.

Implementation of an enhanced recovery after surgery program including a patient school: Impact on quality of life results.

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2022, Injury.

Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co‐administration

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2016, Journal of clinical pharmacy and therapeutics.

Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct‐acting antivirals: The GRUviC project

C. Rodriguez-Gonzalez, I. Iglesias-Peinado, A. Gimenez-Manzorro, 2017, International journal of clinical practice.

Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2018, Revista brasileira de anestesiologia.

Detection of galactomannan content in generic piperacillin-tazobactam products

A. Gimenez-Manzorro, E. Aznar, J. Saez de la Fuente, 2018, Infectious Diseases.

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study.

J. Herrero, A. Aldaz, J. Cortijo, 2015, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

C. Rodriguez-Gonzalez, C. Fernández-Llamazares, V. Escudero-Vilaplana, 2016, The Annals of pharmacotherapy.

Cancellations of elective surgical procedures due to inadequate management of chronic medications

M. Sanjurjo-Sáez, A. Gimenez-Manzorro, S. Ibáñez-García, 2019, Journal of clinical pharmacy and therapeutics.

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, Expert opinion on drug safety.

Information leaflets for patients with hepatitis C receiving treatment with triple therapy

C. Rodriguez-Gonzalez, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2012 .

COVID-19 in hospitalised patients in Spain: a cohort study in Madrid

C. Rodriguez-Gonzalez, E. Bouza, P. Muñoz, 2020, International Journal of Antimicrobial Agents.

Hepatitis C virus infection and the role of a pharmaceutical care program.

C. Rodriguez-Gonzalez, A. Gimenez-Manzorro, M. Sanjurjo, 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Sofosbuvir/ledipasvir as treatment of hepatitis C virus genotype 5 infection: Two case reports.

A. Gimenez-Manzorro, M. Sanjurjo, E. Chamorro-de-Vega, 2017, Medicina clinica.

Octreotide long-active release in the treatment of gastrointestinal bleeding due to vascular malformations: Cost-effectiveness study.

A. Gimenez-Manzorro, G. Clemente-Ricote, J. A. Pajares-Díaz, 2015, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

DD-014 Staff satisfaction after the implementation of a robotic dispensing system in an outpatient pharmacy

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016 .

Cardiovascular Toxicity and Sorafenib: A Case Report

M. Sanjurjo-Sáez, A. Gimenez-Manzorro, L. Cortejoso, 2014, American journal of therapeutics.

Medication guide for the perioperative management of oral antineoplastic agents in cancer patients

V. Escudero-Vilaplana, A. Gimenez-Manzorro, M. Sanjurjo, 2021, Expert opinion on drug safety.

Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice

A. Herranz-Alonso, V. Escudero-Vilaplana, A. Gimenez-Manzorro, 2019, Expert opinion on drug safety.

[TRANSLATED ARTICLE] Achieving excellence in the pharmaceutical care of the surgical patient.

A. Herranz-Alonso, M. Sanjurjo-Sáez, M. L. Martin-Barbero, 2023, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Achieving excellence in the pharmaceutical care of the surgical patient.

A. Herranz-Alonso, M. Sanjurjo-Sáez, M. L. Martin-Barbero, 2023, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study.

J. Herrero, A. Aldaz, J. Cortijo, 2015, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.